Nikolas Evripidou
Papers
14
Total Citations
160
H-Index
9
About
Nikolas Evripidou is a biomedical engineer and researcher specializing in the design and development of magnetic resonance-guided focused ultrasound (MRgFUS) robotic systems for oncological applications. His work sits at the intersection of medical robotics, therapeutic ultrasound, and MRI-compatible engineering, with a focus on creating minimally invasive, image-guided solutions for cancer treatment. Evripidou has made significant contributions to the field by developing a range of MRI-compatible robotic platforms capable of targeting diverse cancer types, including prostate, abdominal, thyroid, breast, and bone tumors. His 2021 transrectal prostate cancer system, one of his most cited works with 24 citations, demonstrated precise five-degree-of-freedom robotic control integrated with MRI guidance. He has also pioneered veterinary oncology applications of MRgFUS technology, demonstrating its efficacy in treating canine and feline sarcomas. Beyond hardware development, his contributions extend to treatment planning software and rigorous accuracy-testing methodologies for clinical certification. His work on MR compatibility challenges further underscores his commitment to translatable, clinically viable systems. With over 140 cumulative citations across his published research, Evripidou has established himself as a productive and impactful contributor to the growing field of robotic therapeutic ultrasound.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic system for top to bottom MRgFUS therapy of multiple cancer types20 citations · 2022
- 3
- 4Simple methods to test the accuracy of MRgFUS robotic systems15 citations · 2021
- 5Challenges regarding MR compatibility of an MRgFUS robotic system14 citations · 2022
- 6Advanced software for MRgFUS treatment planning12 citations · 2023
- 7
- 8
- 9
- 10